Inventiva (IVA) Operating Income (2019 - 2021)
Inventiva's (IVA) quarterly Operating Income came in at -$16.5 million in Q2 2021, down 68.62% year-on-year from -$52.4 million in Q2 2020, and down 37.21% quarter-over-quarter from -$12.0 million in Q1 2021.
Inventiva (IVA) Operating Income (2019 - 2021) Analysis & Trends
Inventiva's Operating Income history runs 3 years deep, the most recent figure standing at -$16.5 million for Q2 2021.
- On a quarterly basis, Operating Income fell 68.62% year-over-year to -$16.5 million in Q2 2021; TTM through Jun 2021 was -$73.6 million, a N/A change from a year earlier, with the FY2025 full-year figure at -$164.1 million, down 57.45% from the prior year.
- Operating Income fell to -$16.5 million in Q2 2021 per IVA's latest filing, from -$12.0 million in the prior quarter.
- Across five years, Operating Income topped out at -$7.5 million in Q1 2020 and bottomed at -$35.4 million in Q4 2020.
- The 3-year median for Operating Income is -$14.2 million (2021), against an average of -$19.1 million.
- Across the five-year window, Operating Income dropped 5.6% in 2020 and slumped 68.62% in 2021, its largest moves.
- Year by year, Operating Income stood at -$33.6 million in 2019, then dropped by 5.6% to -$35.4 million in 2020, then surged by 53.56% to -$16.5 million in 2021.
- Per Business Quant, the three latest IVA Operating Income figures stand at -$16.5 million (Q2 2021), -$12.0 million (Q1 2021), and -$35.4 million (Q4 2020).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 249.90 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.72 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 493.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -445.22 Mn |
| 10 | Inventiva | 842.48 Mn | 842.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | -16.46 Mn |
| Mar 31, 2021 | -11.99 Mn |
| Dec 31, 2020 | -35.43 Mn |
| Jun 30, 2020 | -9.76 Mn |
| Mar 31, 2020 | -7.51 Mn |
| Dec 31, 2019 | -33.55 Mn |